Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Inflectra
Active Ingredient: Infliximab 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Gensenta llac Sanayii ve Ticaret A.S., Instanbul, Turkey
Celltrion Inc., Incheon, South Korea
   
Product: Lynparza
Active Ingredient: Olaparib 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
AbbVie Limited, Barceloneta, Puerto Rico
AstraZeneca AB, Sodertalje, Sweden
   
Product: Lynparza
Active Ingredient: Olaparib 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
AbbVie Limited, Barceloneta, Puerto Rico
AstraZeneca AB, Sodertalje, Sweden
   
Product: Myozyme
Active Ingredient: Alglucosidase alfa 52.5mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Sanofi-Aventis New Zealand Limited
Manufacturer: Genzyme Ireland Limited, Waterford, Ireland
   
Product: Seretide
Active Ingredients: Fluticasone propionate 8mg equivalent to 50mcg/dose
Salmeterol xinafoate 5.8mg equivalent to salmeterol 25mcg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: Glaxo Wellcome Production, Evreux, France
Glaxo Wellcome SA, Burgos, Spain
   
Product: Seretide
Active Ingredients: Fluticasone propionate 20mg equivalent to 125mcg/dose
Salmeterol xinafoate 5.8mg equivalent to salmeterol 25mcg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: Glaxo Wellcome Production, Evreux, France
Glaxo Wellcome SA, Burgos, Spain
   
Product: Seretide
Active Ingredients: Fluticasone propionate 40mg equivalent to 250mcg/dose
Salmeterol xinafoate 5.8mg equivalent to salmeterol 25mcg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: Glaxo Wellcome Production, Evreux, France
Glaxo Wellcome SA, Burgos, Spain
   
Product: Seretide Accuhaler
Active Ingredients: Fluticasone propionate 100mcg
Salmeterol xinafoate 72.5mcg equivalent to 50mcg of salmeterol base
Dosage Form: Powder for inhalation
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: Glaxo Operations UK Limited t/a Glaxo Welcome Operations, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
GlaxoSmithKline LLC, North Carolina, United States of America
   
Product: Seretide Accuhaler
Active Ingredients: Fluticasone propionate 250mcg
Salmeterol xinafoate 72.5mcg equivalent to 50mcg of salmeterol base
Dosage Form: Powder for inhalation
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: Glaxo Operations UK Limited t/a Glaxo Welcome Operations, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
GlaxoSmithKline LLC, North Carolina, United States of America
   
Product: Trajentamet
Active Ingredients: Linagliptin 2.5mg
Metformin hydrochloride 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturers: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
Dragenopharm, Apotheker Puschl GmbH & Co. KG, Tittmoning, Germany
   
Product: Trajentamet
Active Ingredients: Linagliptin 2.5mg
Metformin hydrochloride 850mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturers: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
Dragenopharm, Apotheker Puschl GmbH & Co. KG, Tittmoning, Germany
   
Product: Trajentamet
Active Ingredients: Linagliptin 2.5mg
Metformin hydrochloride 1000mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturers: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
Dragenopharm, Apotheker Puschl GmbH & Co. KG, Tittmoning, Germany
   
Product: ViruPOS
Active Ingredient: Aciclovir 30mg/g
Dosage Form: Eye ointment
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Ursapharm Arzneimittel GmbH, Saarbrucken, Germany


Dated this 9th day of August 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).